US20110263633A1 - Up to six weeks treatment regimen for treating actinic keratoses with pharmaceutical compositions formulated with 2.5% imiquimod - Google Patents

Up to six weeks treatment regimen for treating actinic keratoses with pharmaceutical compositions formulated with 2.5% imiquimod Download PDF

Info

Publication number
US20110263633A1
US20110263633A1 US13/179,336 US201113179336A US2011263633A1 US 20110263633 A1 US20110263633 A1 US 20110263633A1 US 201113179336 A US201113179336 A US 201113179336A US 2011263633 A1 US2011263633 A1 US 2011263633A1
Authority
US
United States
Prior art keywords
imiquimod
treatment
week
formulation
gw01
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/179,336
Inventor
Michael T. Nordsiek
Sharon F. Levy
James H. Lee
James H. Kulp
Kodumudi S. Balaji
Tze-Chiang Meng
Jason J. Wu
Valyn S. Bahm
Robert Babilon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medicis Pharmaceutical Corp
Original Assignee
Graceway Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US13953608P priority Critical
Priority to US14473109P priority
Priority to US20514509P priority
Priority to US12/636,613 priority patent/US20110021555A1/en
Application filed by Graceway Pharmaceuticals LLC filed Critical Graceway Pharmaceuticals LLC
Priority to US13/179,336 priority patent/US20110263633A1/en
Publication of US20110263633A1 publication Critical patent/US20110263633A1/en
Assigned to MEDICIS PHARMACEUTICAL CORPORATION reassignment MEDICIS PHARMACEUTICAL CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GRACEWAY PHARMACEUTICALS, LLC
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42316709&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20110263633(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application status is Abandoned legal-status Critical

Links